ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,000, issued on Oct. 6, was assigned to Orionis Biosciences Inc. (Waltham, Mass.), VIB VZW (Ghent, Belgium) and Universiteit Gent (Ghent, Belgium).

"Immunostimulatory adjuvants" was invented by Nikolai Kley (Waltham, Mass.), Jan Tavernier (Balegem, Belgium), Frank Peelman (Gentbrugge, Belgium), Sarah Gerlo (Ghent, Belgium) and Bram Van Den Eeckhout (Ghent, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to vaccine compositions, adjuvants, chimeric proteins, or chimeric protein complexes and their use as vaccines or therapeutic agents. The present invention further relates to methods of vaccination or trea...